EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Ca binding of rat fibrinogen and fibrin(ogen) degradation products



Ca binding of rat fibrinogen and fibrin(ogen) degradation products



Febs Letters 93(1): 177-180




(PDF same-day service: $19.90)

Accession: 038918208

Download citation: RISBibTeXText

PMID: 100347

DOI: 10.1016/0014-5793(78)80831-x



Related references

Use of monoclonal antibodies to fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis. NATO ASI series Series A Life sciences19(219): 189-197, 1991

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemporary Oncology 17(2): 113-119, 2013

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9(1): 109-121, 1989

Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy. Scandinavian Journal of Respiratory Diseases 59(4): 210-215, 1978

Measuring plasma fibrinogen levels in patients with liver cirrhosis: The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays. Thrombosis Research 78(4): 353-362, 1995

The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes. Thrombosis Research 16(5-6): 705-713, 1979

Comparison of the potentiating effect of fibrinogen fibrinogen degradation products and fibrin degradation products on the amidolytic activity of the plasminogen strepto kinase complex improvement of plasminogen determination in biological samples by decreasing the influence of fibrin degradation products. Thrombosis & Haemostasis 50(1): 56, 1983

Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC. Rinsho Byori. Japanese Journal of Clinical Pathology 41(12): 1349-1352, 1993

Enhancement of amidolytic activity on chromogenic substrate of strepto kinase plasminogen complex induced by fibrin degradation products comparison of potentiator activity between fibrinogen fibrinogen degradation products d or e and fibrin split products early and late stages. Haemostasis 11(SUPPL 1): 98, 1982

Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xin Xue Guan Bing Za Zhi 36(1): 62-67, 2009

Effect of fibrinogen, fibrin and fibrin ogen degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xinxueguanbing Zazhi 36(1): 62-67, 2008

Calcium-binding properties of human fibrin(ogen) and degradation products. Febs Letters 98(2): 257-259, 1979

Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients. Chinese Medical Journal 128(6): 727-732, 2015

Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products. Thrombosis Research 22(5-6): 653-657, 1981